These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22623285)

  • 1. The effects of the preferential dopamine D(3) receptor antagonist S33138 on ethanol binge drinking in C57BL/6J mice.
    Rice OV; Patrick J; Schonhar CD; Ning H; Ashby CR
    Synapse; 2012 Nov; 66(11):975-8. PubMed ID: 22623285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selective dopamine D₃ receptor antagonist SB-277011-A significantly decreases binge-like consumption of ethanol in C57BL/J6 mice.
    Rice OV; Schonhar CA; Gaál J; Gardner EL; Ashby CR
    Synapse; 2015 Jun; 69(6):295-8. PubMed ID: 25764479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats.
    Peng XQ; Ashby CR; Spiller K; Li X; Li J; Thomasson N; Millan MJ; Mocaër E; Muńoz C; Gardner EL; Xi ZX
    Neuropharmacology; 2009 Mar; 56(4):752-60. PubMed ID: 19136017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activity and induction of side effects.
    Millan MJ; Loiseau F; Dekeyne A; Gobert A; Flik G; Cremers TI; Rivet JM; Sicard D; Billiras R; Brocco M
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1212-26. PubMed ID: 18096759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures.
    Millan MJ; Buccafusco JJ; Loiseau F; Watson DJ; Decamp E; Fone KC; Thomasson-Perret N; Hill M; Mocaer E; Schneider JS
    Int J Neuropsychopharmacol; 2010 Sep; 13(8):1035-51. PubMed ID: 20663270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binge-like consumption of ethanol and other salient reinforcers is blocked by orexin-1 receptor inhibition and leads to a reduction of hypothalamic orexin immunoreactivity.
    Olney JJ; Navarro M; Thiele TE
    Alcohol Clin Exp Res; 2015 Jan; 39(1):21-9. PubMed ID: 25623402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice.
    Navarro M; Luhn KL; Kampov-Polevoy AB; Garbutt JC; Thiele TE
    Alcohol Clin Exp Res; 2019 May; 43(5):783-790. PubMed ID: 30817015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
    Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
    J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol alters the activation of ERK1/2, a functional regulator of binge alcohol drinking in adult C57BL/6J mice.
    Agoglia AE; Sharko AC; Psilos KE; Holstein SE; Reid GT; Hodge CW
    Alcohol Clin Exp Res; 2015 Mar; 39(3):463-75. PubMed ID: 25703719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binge ethanol-drinking potentiates corticotropin releasing factor R1 receptor activity in the ventral tegmental area.
    Sparta DR; Hopf FW; Gibb SL; Cho SL; Stuber GD; Messing RO; Ron D; Bonci A
    Alcohol Clin Exp Res; 2013 Oct; 37(10):1680-7. PubMed ID: 23763790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of mGluR5 Antagonism During Binge Drinkingon Subsequent Ethanol Intake in C57BL/6J Mice: Sex- and Age-Induced Differences.
    Cozzoli DK; Strong-Kaufman MN; Tanchuck MA; Hashimoto JG; Wiren KM; Finn DA
    Alcohol Clin Exp Res; 2014 Mar; 38(3):730-738. PubMed ID: 27695144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRF1 receptor signaling regulates food and fluid intake in the drinking-in-the-dark model of binge alcohol consumption.
    Giardino WJ; Ryabinin AE
    Alcohol Clin Exp Res; 2013 Jul; 37(7):1161-70. PubMed ID: 23398267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Alcohol-Preferring Mice Show Reaction to Loss of Ethanol Reward Following Repeated Binge Drinking.
    Ardinger CE; Grahame NJ; Lapish CC; Linsenbardt DN
    Alcohol Clin Exp Res; 2020 Sep; 44(9):1717-1727. PubMed ID: 32865852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin Releasing Factor Binding Protein and CRF2 Receptors in the Ventral Tegmental Area: Modulation of Ethanol Binge Drinking in C57BL/6J Mice.
    Albrechet-Souza L; Hwa LS; Han X; Zhang EY; DeBold JF; Miczek KA
    Alcohol Clin Exp Res; 2015 Sep; 39(9):1609-18. PubMed ID: 26247973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of the 20% alcohol intermittent access model in Sardinian alcohol-preferring rats: a model of binge-like drinking.
    Sabino V; Kwak J; Rice KC; Cottone P
    Alcohol Clin Exp Res; 2013 Apr; 37(4):635-43. PubMed ID: 23126554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serotonin 2C receptor agonist lorcaserin, alone and in combination with the opioid receptor antagonist naltrexone, attenuates binge-like ethanol drinking.
    Tabbara RI; Li Z; Fletcher PJ; Lê AD
    Addict Biol; 2021 Sep; 26(5):e13040. PubMed ID: 33928736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated cycles of binge-like ethanol (EtOH)-drinking in male C57BL/6J mice augments subsequent voluntary EtOH intake but not other dependence-like phenotypes.
    Cox BR; Olney JJ; Lowery-Gionta EG; Sprow GM; Rinker JA; Navarro M; Kash TL; Thiele TE
    Alcohol Clin Exp Res; 2013 Oct; 37(10):1688-95. PubMed ID: 23647551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice.
    Navarro M; Carvajal F; Lerma-Cabrera JM; Cubero I; Picker MJ; Thiele TE
    Alcohol Clin Exp Res; 2015 Aug; 39(8):1425-33. PubMed ID: 26108334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing kynurenine brain levels reduces ethanol consumption in mice by inhibiting dopamine release in nucleus accumbens.
    Giménez-Gómez P; Pérez-Hernández M; Gutiérrez-López MD; Vidal R; Abuin-Martínez C; O'Shea E; Colado MI
    Neuropharmacology; 2018 Jun; 135():581-591. PubMed ID: 29705534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.
    Millan MJ; Svenningsson P; Ashby CR; Hill M; Egeland M; Dekeyne A; Brocco M; Di Cara B; Lejeune F; Thomasson N; Munoz C; Mocaër E; Crossman A; Cistarelli L; Girardon S; Iob L; Veiga S; Gobert A
    J Pharmacol Exp Ther; 2008 Feb; 324(2):600-11. PubMed ID: 18024787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.